<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>PR.com Press Releases: G&amp;L Scientific Inc News</title>
		<link>https://www.PR.com/</link>
		<description>Latest news releases from PR.com for G&amp;L Scientific Inc.</description>
		<lastBuildDate>Sun, 11 Oct 2026 17:20:49 -0400</lastBuildDate>
		<copyright>&#169; 2026 PR.com</copyright>
		<ttl>60</ttl>
		<language>en-us</language>
		<image>
			<url>https://www.PR.com/images/logo_white.jpg</url>
			<title>PR.com Press Releases: G&amp;L Scientific Inc News</title>
			<link>https://www.PR.com/</link>
			<width>68</width>
			<height>69</height>
			<description>PR.com provides press release distribution, and is a unique directory of businesses, products and services. Find full company profiles.</description>
		</image>
		<atom:link href="https://www.pr.com/rss/press-releases-2/396171.xml" rel="self" type="application/rss+xml" />
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/732210</guid>
			<title>G&amp;L Scientific Announces the Appointment of Richard Edmunds as Vice President, Regulatory Affairs</title>
			<pubDate>Mon, 09 Oct 2017 10:12:00 -0400</pubDate>
			<description>Global provider of Clinical &amp; Regulatory Affairs consultancy services continues to attract top talent. [PR.com]</description>
			<link>https://www.pr.com/press-release/732210</link>
			<dc:creator>G&amp;L Scientific Inc</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/718470</guid>
			<title>G&amp;l Scientific Inc. Announces Its Expansion Into Regulatory Affairs, Complementing Its Industry-Leading Clinical Research Offering</title>
			<pubDate>Fri, 02 Jun 2017 03:00:00 -0400</pubDate>
			<description>G&#38;L Scientific Inc, a company founded by Peter Griffin and Stephen Loughrey, who together built Pharmalink Consulting into the leading, independent Regulatory Affairs specialist, today announced their intention to once more provide Regulatory Affairs services to life-science clients.  G&#38;L Scientific, launched after the sale of Pharmalink to Genpact in 2014, has been working in the Clinical Research sector, and has [PR.com]</description>
			<link>https://www.pr.com/press-release/718470</link>
			<dc:creator>G&amp;L Scientific Inc</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/702278</guid>
			<title>G&amp;L Scientific Inc. Announces Opening of New Offices in Cambridge, Massachusetts</title>
			<pubDate>Thu, 19 Jan 2017 10:10:00 -0500</pubDate>
			<description>G&amp;L Scientific Inc, the leading provider of clinical and scientific consulting and resource to the healthcare industry (http://www.gandlscientific.com), has announced the opening of new offices in Cambridge, Massachusetts, strengthening and improving access to its expanding team of clinical and scientific consultants and contractors. This is the latest step in G&amp;L’s expansion of its global clinical consulting services [PR.com]</description>
			<link>https://www.pr.com/press-release/702278</link>
			<dc:creator>G&amp;L Scientific Inc</dc:creator>
		</item>
	</channel>
</rss>